Learn about Arbutus's promising Hepatitis B treatments, strong financial position, and projections for the global market.

Inpegsomatropin is under clinical development by Xiamen Amoytop Biotech and currently in Phase II for Turner Syndrome.

LipoMedix Pharmaceutical (LipoMedix) operates as a developer of drugs for cancer therapy based on liposome delivery. The company’s product Promitil is a chemotherapeutic agent, which is used for ...

INR:8733. 1:00 result PAG acquires 3.828 billion shares of Hisun Biotech and Hisun Pharmaceuticals gives up its position as a major shareholder Qilu pegylated recombi ...

INR:4716. kabaddi rules and regulations pdf The turning point of the prescription restriction of Chinese patent medicine has ...

INR:6461. roulette machine how to win Pegylated interferon λ receives FDA breakthrough therapy designation for the treatment of hepatitis delta New d ...

Anime gaming logo List of top 20 drugs in terms of sales volume announced Qilu pegylated recombinant human granulocyte-stimulating factor injection dr ...

INR:3905. 48 jersey number in cricket india Yifeng Pharmacy's revenue surged by 2 billion yuan year-on-year Layoffs just after establishment? Hu ...

INR:6427. casino dubai IN10018 of Inshi Biopharma and Cobimetinib reach global combination drug clinical cooperation Latest notice: These medicines have rebates Pegy ...

Brain: Is left-handedness not an acquired habit but determined by genes? Inventory | More than 20 Chinese new drugs that received FDA orphan drug status in 2020 Pegylated interferon λ receives FDA bre ...

34 patients), xalnesiran 200 mg + pegylated interferon alfa-2a 180 µg (group 4; 30 patients), or NA alone (group 5; 35 patients). The primary efficacy end point was HBsAg loss at 24 weeks after ...

Here, we report the first case of a CNL patient positive for a de-novo germline CSF3R T618I variant effectively treated with ruxolitinib and pegylated interferon (peg-IFN), obtaining normalization of ...